An interventional study of adapted Chicago Run running program in Cerebral Palsy, Myelomeningocele and Arthrogryposis, sponsored by Northwestern University. Enrolling by invitation at 1 site in United States. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-08-18.
Sponsored by Northwestern University · Not applicable, Interventional, and Treatment
Barriers to keeping and maintaining fitness as a young person with a disability exist across many domains of access to community locations such as fitness centers, so looking outside of these establishments may be necessary to advance fitness. This study is aimed at piloting a program that would address some of these barriers by hosting a modified after school running program with an underserved population in an accessible way. There is a second option to participate outside of school.
1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.
This study's planned enrollment of 25 is below the median of 34 across 1,431 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Northwestern University is the lead sponsor of 1,423 studies on the registry; 198 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants that will join the running program.
Behavioral: adapted Chicago Run running program
The intervention being piloted is a 6-8 week running program modified from a running curriculum designed for school-aged children. The children will use a RaceRunner device to facilitate their participation, but this device is not explicitly evaluated in this study. Depending on transportation, they may be given access to the device in their home or school between sessions after it has been fit for them. If given access, guardians will be instructed on care and usage.
Goal attainment scale
a tool designed to standardize the setting and scaling of goals in a way that allows for both improvement and regression as a result of intervention.
Time frame: at 8 weeks.
6 min walk test
Participant will walk as far as they can in 6 minutes, as a measure of endurance
Time frame: baseline
6 min walk test
Participant will walk as far as they can in 6 minutes, as a measure of endurance
Time frame: at 8 weeks
30 second walk test
Participant will walk as fast as they can for 30 seconds, as a measure of speed.
Time frame: baseline
30 second walk test
Participant will walk as fast as they can for 30 seconds, as a measure of speed.
Time frame: at 8 weeks
Resting heart rate
Participant heart rate after 5 minutes of quiet sitting
Time frame: baseline
Resting heart rate
Participant heart rate after 5 minutes of quiet sitting
Time frame: at 8 weeks
Surveys
Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength
Time frame: baseline
Surveys
Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength
Time frame: at 8 weeks
Selective Control Assessment of the Lower Extremity (SCALE)
a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity. Min score=0; max score=16, a higher score is a better outcome
Time frame: baseline
Selective Control Assessment of the Lower Extremity (SCALE)
a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity Min score=0; max score=16, a higher score is a better outcome
Time frame: at 8 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.